Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria

BACKGROUND Pregnancy-associated malaria caused by Plasmodium falciparum adherence to chondroitin sulfate A in the placental intervillous space is a major cause of low birthweight and maternal anaemia in areas of endemic P falciparum transmission. Adhesion-blocking antibodies that specifically recognise parasite-encoded variant surface antigens (VSA) are associated with resistance to pregnancy-associated malaria. We looked for a possible relation between VSA-specific antibody concentrations, placental infection, and protection from low birthweight and maternal anaemia. METHODS We used flow cytometry to measure VSA-specific IgG concentrations in plasma samples taken during child birth from 477 Kenyan women selected from a cohort of 910 women on the basis of HIV-1 status, gravidity, and placental histology. We measured VSA expressed by one placental P falciparum isolate and two isolates selected or not selected for chondroitin sulfate A adhesiveness in-vitro. FINDINGS Concentrations of plasma IgG specific for VSA, expressed by chondroitin sulfate A-adhering parasites (VSA in pregnancy-associated malaria or vsa-pam), increased with gravidity and were associated with placental histological findings. Women with chronic pregnancy-associated malaria and low or absent VSA-PAM-specific IgG had lower haemoglobin values (reduced by 17 g/L; 95% CI 8.1-25.2) and delivered smaller babies (birthweight reduced by 0.26 kg; 0.10-0.55) than did corresponding women with high VSA-PAM-specific IgG. No such relation was shown for concentrations of IgG with specificity for non-pregnancy-associated malaria VSA. INTERPRETATION VSA-PAM-specific IgG protects against low birthweight and maternal anaemia. Our data indicate an important mechanism of clinical protection against malaria and raise hope for the clinical effectiveness of a potential VSA-based vaccine against pregnancy-associated malaria.

[1]  T. Theander,et al.  Malaria-Induced Acquisition of Antibodies to Plasmodium falciparum Variant Surface Antigens , 2002, Infection and Immunity.

[2]  Jonathan E. Allen,et al.  Genome sequence of the human malaria parasite Plasmodium falciparum , 2002, Nature.

[3]  L. Hviid,et al.  Expression of Variant Surface Antigens by Plasmodium falciparum Parasites in the Peripheral Blood of Clinically Immune Pregnant Women Indicates Ongoing Placental Infection , 2003, Infection and Immunity.

[4]  Patrick E. Duffy,et al.  Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta , 1996, Science.

[5]  M. Valiyaveettil,et al.  Gravidity-Dependent Production of Antibodies That Inhibit Binding of Plasmodium falciparum-Infected Erythrocytes to Placental Chondroitin Sulfate Proteoglycan during Pregnancy , 2001, Infection and Immunity.

[6]  B. Gamain,et al.  Plasmodium falciparum domain mediating adhesion to chondroitin sulfate A: a receptor for human placental infection. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[7]  K. Marsh,et al.  Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae , 2001, Tropical medicine & international health : TM & IH.

[8]  B. Brabin.  An analysis of malaria in pregnancy in Africa. , 1983, Bulletin of the World Health Organization.

[9]  T. Theander,et al.  Plasma Antibodies from Malaria-Exposed Pregnant Women Recognize Variant Surface Antigens on Plasmodium falciparum-Infected Erythrocytes in a Parity-Dependent Manner and Block Parasite Adhesion to Chondroitin Sulfate A1 , 2000, The Journal of Immunology.

[10]  S. Kyes,et al.  Antigenic variation at the infected red cell surface in malaria. , 2001, Annual review of microbiology.

[11]  M. Fried,et al.  Antibodies That Inhibit Plasmodium falciparum Adhesion to Chondroitin Sulfate A Are Associated with Increased Birth Weight and the Gestational Age of Newborns , 2003, Infection and Immunity.

[12]  B. Okoko,et al.  The epidemiology and consequences of maternal malaria: a review of immunological basis. , 2003, Acta tropica.

[13]  A. Cowman,et al.  The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by P. falciparum erythrocyte membrane protein 1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Theander,et al.  Detection of antibodies to variant antigens on Plasmodium falciparum-infected erythrocytes by flow cytometry. , 1999, Cytometry.

[15]  R. Steketee,et al.  RAPID SPONTANEOUS POSTPARTUM CLEARANCE OF PLASMODIUM FALCIPARUM PARASITAEMIA IN AFRICAN WOMEN , 1988, The Lancet.

[16]  L. Chitsulo,et al.  Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. , 1996, American Journal of Tropical Medicine and Hygiene.

[17]  R. Leke,et al.  Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. , 2001, The Journal of infectious diseases.

[18]  M. Valiyaveettil,et al.  Characterization of Proteoglycans of Human Placenta and Identification of Unique Chondroitin Sulfate Proteoglycans of the Intervillous Spaces That Mediate the Adherence ofPlasmodium falciparum-infected Erythrocytes to the Placenta* , 2000, The Journal of Biological Chemistry.

[19]  R. Steketee,et al.  Plasmodium falciparum associated placental pathology: a light and electron microscopic and immunohistologic study. , 1989, The American journal of tropical medicine and hygiene.

[20]  François Nosten,et al.  Maternal antibodies block malaria , 1998, Nature.

[21]  J. Rowe,et al.  Expanding the paradigms of placental malaria. , 2002, Trends in parasitology.

[22]  S. Kyes,et al.  Identification of a conserved Plasmodium falciparum var gene implicated in malaria in pregnancy. , 2002, The Journal of infectious diseases.

[23]  R. Snow,et al.  The epidemiology and burden of Plasmodium falciparum-related anemia among pregnant women in sub-Saharan Africa. , 2001, The American journal of tropical medicine and hygiene.

[24]  T. Theander,et al.  A sub-family of common and highly conserved Plasmodium falciparum var genes. , 2002, Molecular and biochemical parasitology.

[25]  R. Snow,et al.  Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[26]  Thomas Lavstsen,et al.  Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A‐adhering Plasmodium falciparum involved in pregnancy‐associated malaria , 2003, Molecular microbiology.

[27]  B. Greenwood,et al.  Placental malaria. I. Pathological classification , 1993, Histopathology.

[28]  Kevin Marsh,et al.  Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria , 1998, Nature Medicine.